用于治疗牛皮的高药载荷纳米颗粒凝的局部输送
Zihan Zhao1,2, Letao Xu2, Yun Liu2
1Department of Dermatology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
Journal of nanobiotechnology
|February 14, 2026
概括
这项研究开发了用于局部牛皮治疗的新型纳米颗粒凝,有效地提供阿普雷米拉斯,改善皮肤屏障功能并减少炎症. 这些先进的药物输送系统为治疗牛皮提供了一种患者友好的方法.
科学领域:
- 皮肤病学和纳米技术
- 药理学和药物输送 药理学和药物输送
背景情况:
- 牛皮涉及表皮增生和皮肤屏障功能受损,阻碍局部药物输送.
- 目前的局部治疗由于牛皮病变中角层变厚而面临挑战.
- 阿普雷米拉斯特 (APR) 是FDA批准的治疗牛皮的口服药物.
研究的目的:
- 开发一种高药载荷局部药物输送 (TDD) 系统,以有效地在牛皮中输送阿普雷米拉斯 (APR).
- 创建脂质纳米颗粒 (LNP) 和聚合物纳米颗粒 (PNP) 装有40%的APR,并将其嵌入Carbopol 940凝中.
主要方法:
- 使用顺序纳米沉合成APR载荷的LNP和PNP.
- 配制的纳米粒子加载的Carbopol 940凝 (LNPG和PNPG).
- 通过ex vivo皮肤研究和因米奎莫德诱导的牛皮小鼠模型评估配方.
主要成果:
- 液态天然气显示出增强的皮内保留,而PNPG显示出更大的皮下积累.
- 两种LNPG和PNPG治疗都显著改善了小鼠牛皮的临床症状.
- 这些配方减少了表皮厚度,大小,以及与牛皮相关的关键细胞因子.
结论:
- 高药量纳米颗粒凝显示出用于局部牛皮管理的显著治疗潜力.
- 这些NP凝代表了一种有希望的,患者友好的TDD平台,用于牛皮和其他障碍性皮肤病.
相关概念视频
Drug Delivery: Overview
937
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
937
Drug Delivery: Enteral Route
1.9K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.9K
Drug Delivery: Parenteral Route
1.8K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.8K
Transdermal Drug Delivery Systems
23
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
23
Ophthalmic Drug Delivery Systems
22
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
22
Intrauterine Drug Delivery Systems
20
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
20


